Traumatic brain injury (TBI) is a common and often devastating health issue. Among the many forms of TBI, mild traumatic brain injury (mTBI) or concussive brain injury constitutes the most common form (
1). Thus, mTBI affects more people and occurs more frequently than the more severe forms of TBI. Mild traumatic brain injury has been associated with, or causes diffuse neuronal damage, apoptosis and metabolic changes (
2,
3). Although 80%-90% of all mTBI effects are resolved spontaneously within a couple of weeks, some functional ailments can persist for months (
4). Axonal injury has been suggested to be a primary factor of adverse outcomes following TBI (
5). Furthermore, TBI has been proposed to be a risk and initiating factor for the later development of neurodegenerative diseases, including Alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) (
1). Several studies observed a history of TBI to be the strongest epigenetic risk factor for neurodegenerative diseases (
6-
9). The diagnostic histopathological defects of AD are amyloid plaques and neurofibrillary threads and tangles (NFT) composed of hyperphosphorylated protein tau (
10). Protein tau is a cytoplasmic, microtubule-associated protein (MAP) that is normally mainly present or enriched in axons.
Many neurodegenerative diseases are caused by aggregation of protein tau in different brain regions and types of neurons without any indications of amyloid plaque deposition, and are commonly designated as tauopathies (
11-
14). Various mutations in the tau-encoding gene cause subtypes of frontotemporal dementia clinically similar to AD, which itself is a secondary tauopathy. In AD, tau pathology but not amyloid deposition correlates with disease severity and cognitive decline (
15). Tau pathology has been documented in brain of humans after severe TBI and in boxers who sustained a number of concussions resulting in CTE, eventually resulting in dementia pugilistica (
16-
18). Open-skull TBI accelerated tau pathology in young 3xTg-AD and Tau.P301L mice, resembling human tauopathy in both axonal and somatodendritic compartments (
19). The posttraumatic tau pathology seemed to be independent of amyloid pathology. Furthermore, closed-skull mTBI in APP/PS1 knock-in mice led to greater cognitive impairment via mechanisms that involved neuroinflammatory responses mediated by glia, while eventual tau-mediated pathology was not investigated (
20). However, it remains unclear whether and how closed-skull mTBI affects hippocampal synaptic plasticity, a sensitive marker of synaptic pathology, in a tauopathy model (
20-
22). Therefore, we examined in Tau.P301L mice that model tauopathy associated with fronto-temporal dementia and AD (
23) whether mTBI induced by closed-head injury (
24) led to chronic changes in hippocampal synaptic plasticity.